Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03332537 · ClinicalTrials.gov registry record · NA
Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome
A NA study of Irritable Bowel Syndrome, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT03332537: Completed NA study of Irritable Bowel Syndrome, sponsored by University of Connecticut.
NCT03332537 is a NA study of Irritable Bowel Syndrome that has completed, run by University of Connecticut. The registered enrollment target is 80 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03332537, a NA study of Irritable Bowel Syndrome, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot project will provide foundational information about the contextual factors of irritable bowel syndrome (IBS) related pain (pain catastrophizing, perceived stress, reactivity pain sensitivity, genetic and microbiome) on pain self-management (SM) process and outcomes. In addition, the investigators will gain insight on the potential impact of the personalized IBS-pain SM approach on pain SM behaviors and health outcomes.
Primary Outcome
Quantitative sensory testing - Change over time
Conditions Studied
Interventions
- BEHAVIORAL Personalized IBS Pain SM
Study Locations (2)
Connecticut
- UConn Health Center - Farmington
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03332537 record still lists
NCT03332537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Personalized IBS Pain SM is the first listed.
NCT03332537 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03332537 about?
NCT03332537 is a clinical study titled "Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome". This pilot project will provide foundational information about the contextual factors of irritable bowel syndrome (IBS) related pain (pain catastrophizing, perceived stress, reactivity pain sensitivity, genetic and microbiome) on pain self-management (SM) process and outcomes. In addition, the inves...
What is the current status of trial NCT03332537?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-10-01. Estimated completion is 2018-12-31.
What conditions does trial NCT03332537 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
What interventions are being tested in trial NCT03332537?
The interventions under investigation include: Personalized IBS Pain SM (BEHAVIORAL).
Who is sponsoring clinical trial NCT03332537?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03332537 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03332537's enrollment target sits among peer trials
80 25th of 47 higher than 22 of 47 other Irritable Bowel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
Visible Abdominal Distension
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI